CAN FITE BIOPHARMA LTD (CANF)
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Baker Hughes Announces Dates for Second-Quarter Earnings Release and Webcast
Highlander Silver Announces Results of Annual General Meeting of Shareholders
Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access
Ermenegildo Zegna Group Reports Voting Results of the Annual General Meeting Held on June 26, 2026
Catalyst Bancorp, Inc. and Lakeside Bancshares, Inc. Announce Shareholder and Regulatory Approvals for Pending Mergers
Aurora Mobile’s JPush Empowers Yuanda Information’s Caiyuan Gungun App with Millisecond-Level, Precise User Engagement
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
New Autism Research to be Presented at European Purine Scientific Meeting